# COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study

> **NCT04746430** · PHASE4 · TERMINATED · sponsor: **General Practitioners Research Institute** · enrollment: 17 (actual)

## Conditions studied

- Covid19
- Corona Virus Infection

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04746430
- **Lead sponsor:** General Practitioners Research Institute
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-16
- **Primary completion:** 2021-04-23
- **Final completion:** 2021-04-23
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Too few patients
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04746430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04746430, "COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04746430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*